Genome-wide CRISPR screen identifies ACSL3 as a regulator of lipotoxicity and progression of MASLD.

Key Points

• This research aims to explore the role of ACSL3 in lipotoxicity and the progression of MASLD.
• Conducted a genome-wide CRISPR screen
• Focused on identifying genes regulating lipotoxicity
• Analyzed the role of ACSL3 in hepatocytes
• Investigated mechanisms linking lipid droplets to cell injury
• ACSL3 was identified as a central regulator of lipotoxicity
• Link between ACSL3 and the formation of inflammatory niches was established
• Findings support ACSL3 as a potential therapeutic target in steatotic liver disease